CT:TH Theratechnologies Inc

Theratechnologies Inc., a specialty pharmaceutical company, addresses unmet medical needs to promote healthy living and improve quality of life among HIV patients. The company's lead product is EGRIFTA, which increases the incidence or progression of diabetic retinopathy in diabetic HIV-infected patients with lipodystrophy and excess abdominal fat in the United States and Canada. Theratechnologies Inc. was founded in 1993 and is headquartered in Montreal, Canada.

This company cross-lists their shares on a U.S. stock exchange. See the related U.S. symbol THTX.

This company has cross-listed shares that trade in the U.S. as the symbol THTX.

1.17 CAD
As of 03/24/2023

---

Security Information

---

Category1:  Global Equity
Category2:  Common stocks
Category3:  Developed markets ex-US
GICS sector:  Health Care
Industry:  Drug Manufacturers-Specialty &
Index country:  Canada
Country of incorporation:  Canada
IPO date:  12/31/1999
Stock exchange:    Toronto Stock Exchange
Exchange country:   Canada
Market cap:   292,974,528 CAD
Current dividend yield:   0.00%
Sedol:      2889906